BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6179608)

  • 1. Monoclonal antibodies to a human prostate antigen.
    Frankel AE; Rouse RV; Wang MC; Chu TM; Herzenberg LA
    Cancer Res; 1982 Sep; 42(9):3714-8. PubMed ID: 6179608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human prostate tissue antigens defined by murine monoclonal antibodies.
    Starling JJ; Sieg SM; Beckett ML; Wirth PR; Wahab Z; Schellhammer PF; Ladaga LE; Poleskic S; Wright GL
    Cancer Res; 1986 Jan; 46(1):367-74. PubMed ID: 2415250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients.
    Horoszewicz JS; Kawinski E; Murphy GP
    Anticancer Res; 1987; 7(5B):927-35. PubMed ID: 2449118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a human cancer-associated antigen defined with monoclonal antibody.
    Bhattacharya M; Chatterjee SK; Barlow JJ
    Cancer Res; 1984 Oct; 44(10):4528-34. PubMed ID: 6380708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
    Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
    Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay.
    Kuriyama M; Wang MC; Papsidero LD; Killian CS; Shimano T; Valenzuela L; Nishiura T; Murphy GP; Chu TM
    Cancer Res; 1980 Dec; 40(12):4658-62. PubMed ID: 6159971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen.
    Kuroki M; Kuroki M; Koga Y; Matsuoka Y
    J Immunol; 1984 Oct; 133(4):2090-7. PubMed ID: 6206151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody immunoglobulin G (IgG) against human prostatic specific antigen (PSA) as a carrier protein for chemotherapeutic drugs to human prostate tumors: Part 1. A double immunofluorescence analysis.
    Sinha AA; Sackrison JL; DeLeon OF; Wilson MJ; Gleason DF
    Anat Rec; 1996 Aug; 245(4):652-61. PubMed ID: 8837723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical characterization of two monoclonal antibodies, P25.48 and P25.91, which define a new prostate-specific antigen.
    Bazinet M; Cote RJ; Cordon-Cardo C; Myc A; Fair WR; Old LJ
    Cancer Res; 1988 Dec; 48(23):6938-42. PubMed ID: 2460231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical localization of prostate carcinoma-associated antigens.
    Wright GL; Beckett ML; Starling JJ; Schellhammer PF; Sieg SM; Ladaga LE; Poleskic S
    Cancer Res; 1983 Nov; 43(11):5509-16. PubMed ID: 6193873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody PR92 with restricted specificity for tumor-associated antigen of prostate and breast carcinoma.
    Kim YD; Robinson DY; Tomita JT
    Cancer Res; 1988 Aug; 48(16):4543-8. PubMed ID: 3396007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary immunohistochemical characterization of a monoclonal antibody (PRO:4-216) prepared from human prostate cancer nuclear matrix proteins.
    Partin AW; Briggman JV; Subong EN; Szaro R; Oreper A; Wiesbrock S; Meyer J; Coffey DS; Epstein JI
    Urology; 1997 Nov; 50(5):800-8. PubMed ID: 9372899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a monoclonal antibody, KR-P8, that detects a new prostate-specific marker.
    Raynor RH; Hazra TA; Moncure CW; Mohanakumar T
    J Natl Cancer Inst; 1984 Sep; 73(3):617-25. PubMed ID: 6206270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
    Epstein AL; Marder RJ; Winter JN; Fox RI
    J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of new prostate specific monoclonal antibodies.
    Lampe MI; Molkenboer-Kuenen JD; Oosterwijk E
    Prostate; 2004 Feb; 58(3):225-31. PubMed ID: 14743460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of monoclonal antibody alpha Pro3 recognizing a human prostatic carcinoma antigen.
    Ware JL; Paulson DF; Parks SF; Webb KS
    Cancer Res; 1982 Apr; 42(4):1215-22. PubMed ID: 6174221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of a human prostate specific antigen.
    Wang MC; Valenzuela LA; Murphy GP; Chu TM
    Invest Urol; 1979 Sep; 17(2):159-63. PubMed ID: 89106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human prostate specific and shared differentiation antigens defined by monoclonal antibodies.
    Frankel AE; Rouse RV; Herzenberg LA
    Proc Natl Acad Sci U S A; 1982 Feb; 79(3):903-7. PubMed ID: 6174984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human monoclonal antibody reactive with human prostate.
    Lowe DH; Handley HH; Schmidt J; Royston I; Glassy MC
    J Urol; 1984 Oct; 132(4):780-5. PubMed ID: 6206243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.